July 15, 2020
Pfizer could have COVID-19 vaccine by October
Editor's Note
Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine.
Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach.
Pfizer CEO Albert Bourla says they should have enough data by September on the success of the vaccine to submit to the FDA. The company plans to begin manufacturing the vaccine ahead of FDA approval.
Free Daily News
- Milestone pig kidney transplant offers hope amid ethical, safety questions
- Fitch Ratings: Hospital credit outlook improves amid stabilizing margins
- Annual Leapfrog Group awards recognize top hospitals, ASCs
- US obesity rates decline for first time in a decade
- Study: Active monitoring without surgery safe for certain low-risk DCIS patients
- Data support option to skip sentinel lymph node biopsy in early breast cancer
- Surveyed nurses, physicians likely to quit
- Costs drop, access expands for GLP-1 weight loss drugs
- Q&A: Perioperative immunotherapy advances for early-stage NSCLC
- Proposals close December 16: Present at the 2025 OR Manager Conference
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement